Stock Events

STPharmLtd 

₩99,100
0
+₩0+0% Heute

Statistik

Tag Hoch
101,900
Tag Tief
97,700
52W Hoch
120,800
52W Niedrig
59,900
Volumen
191,872
Durch. Volumen
509,284
Marktkap.
2.14T
KGV
-
Dividendenrendite
0.5%
Dividende
494.51

Demnächst

Dividenden

0.5%Dividendenrendite
10J Wachstumsrate
K.A.
5J Wachstumsrate
K.A.
3J Wachstumsrate
K.A.
1J Wachstumsrate
K.A.

Gewinne

25JulErwartet
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
309.48
366.88
424.27
481.67
Erwartetes EPS
K.A.
Tatsächliches EPS
K.A.

Leute folgen auch

Diese Liste basiert auf den Watchlists von Personen auf Stock Events, die 237690.KQ folgen. Es handelt sich nicht um eine Anlageempfehlung.

Wettbewerber

Diese Liste ist eine Analyse basierend auf aktuellen Marktereignissen. Es ist keine Anlageempfehlung.

Über

ST Pharm Co. Ltd., a contract development manufacturing organization, provides products for pharmaceutical and non-pharmaceutical area in South Korea. The company offers chemistry manufacturing control (CMC) services, which includes analytical method development; in-house reference standard testing; analytical method qualification/validation; analytical characterization; and CMC documentation. It also provides oligonucleotide based products, such as antisense, siRNA, miRNA, aptamer, CpG, decoy, and other products; and monomer/phosphoramidite. In addition, the company offers generic APIs for anti-cancer, anti-coagulant, anti-fungal, anti-hyperlipidemia, anti-hypertensive, anti-tuberculosis, asthma, COPD, cough suppressant, diabetes mellitus, epilepsy, hepatitis B, and erectile dysfunction medicines, as well as MRI contrast agents. Further, it provides 2nd battery, electronic materials, and polymer catalysts. The company was formerly known as Samchully Pharmaceutical Company., Ltd. ST Pharm Co. Ltd. was founded in 1983 and is based in Seoul, South Korea.
Show more...
CEO
Mr. Geun-Jo Im Ph.D.
Mitarbeiter
566
Land
KR
ISIN
KR7237690003

Börsen